Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Myoinositol on Serum Asprosin Levels in Pregnant Women
NCT05943158Completed
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of myo-inositol in gestational diabetes mellitus (GDM) (2 arms). Primary endpoint: Serum asprosin levels. Started Jun 2021; status: completed.
02
Drugs
myo-inositol
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT05943158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05943158.